CESI, G., WALBRECQ, G., ZIMMER, A. D., KREIS, S., & HAAN, C. (08 June 2017). ROS production induced by BRAF inhibitor treatment rewires metabolic processes affecting cell growth of melanoma cells. Molecular Cancer, 8 (june). doi:10.1186/s12943-017-0667-y Peer Reviewed verified by ORBi |
CESI, G., WALBRECQ, G., MARGUE, C., & KREIS, S. (10 June 2016). Transferring intercellular signals and traits between cancer cells: extracellular vesicles as "homing pigeons". Cell Communication and Signaling, 14 (1), 13. doi:10.1186/s12964-016-0136-z Peer Reviewed verified by ORBi |
ZIMMER, A. D., WALBRECQ, G., KOZAR, I., BEHRMANN, I., & HAAN, C. (2016). Phosphorylation of the PDH complex precedes HIF-1-mediated effects and PDK1 upregulation during the first hours of hypoxic treatment in HCC cells. Hypoxia, 4, 135-145. doi:10.2147/HP.S99044 Peer reviewed |
WALBRECQ, G., Wang, B., Becker, S., Hannotiau, A., Fransen, M., & Knoops, B. (2015). Antioxidant cytoprotection by peroxisomal peroxiredoxin-5. Free Radical Biology and Medicine, 84, 215-26. doi:10.1016/j.freeradbiomed.2015.02.032 Peer Reviewed verified by ORBi |
Van der Eecken, V., Clippe, A., Dekoninck, S., Goemaere, J., WALBRECQ, G., Van Veldhoven, P. P., & Knoops, B. (2013). Abolition of peroxiredoxin-5 mitochondrial targeting during canid evolution. PLoS ONE, 8 (9), 72844. doi:10.1371/journal.pone.0072844 Peer Reviewed verified by ORBi |